Earnings Feed
Start Free
Home/Filings/4/0001179110-20-006839
4//SEC Filing

Howley Michael G 4

Accession 0001179110-20-006839

CIK 0000815094other
View on SEC.govCompany Profile

Filed

Jun 1, 8:00 PM ET

Accepted

Jun 2, 8:35 PM ET

Size

20.3 KB

Accession

0001179110-20-006839

Insider Transaction Report

Form 4
Period: 2020-05-29
ABIOMED INCABMD
Howley Michael G
Vice President
Transactions
  • Award

    Stock Option (right to buy)

    2020-05-29+2,206→ 2,206 total
    Exercise: $223.90From: 2021-05-29Exp: 2030-05-29→ Common Stock (2,206 underlying)
  • Award

    Common Stock, $.01 par value

    2020-05-29+600→ 30,855 total
Holdings

  • Stock Option (Right to Buy)

    Exercise: $266.39From: 2020-05-30Exp: 2029-05-30→ Common Stock (4,000 underlying)
    4,000

  • Stock Option (Right to Buy)

    Exercise: $23.15From: 2014-05-14Exp: 2023-05-14→ Common Stock (0 underlying)
    15,000

  • Stock Option (Right to Buy)

    Exercise: $134.51From: 2018-05-15Exp: 2027-05-15→ Common Stock (0 underlying)
    6,500

  • Stock Option (Right to Buy)

    Exercise: $381.97From: 2019-05-16Exp: 2028-05-16→ Common Stock (0 underlying)
    4,000

  • Stock Option (Right to Buy)

    Exercise: $21.55From: 2015-05-14Exp: 2024-05-14→ Common Stock (0 underlying)
    7,500

  • Common Stock, $.01 par value

    (indirect: By Trust)
    20,510

  • Stock Option (Right to Buy)

    Exercise: $66.25From: 2016-05-13Exp: 2025-05-13→ Common Stock (0 underlying)
    5,000

  • Stock Option (Right to Buy)

    Exercise: $99.62From: 2017-05-24Exp: 2026-05-24→ Common Stock (0 underlying)
    8,000
Footnotes (5)
  • [F1]Grant to reporting person of option to buy the number of shares of common stock set forth on Table II, Column 7, under the Abiomed, Inc. 2008 Stock Incentive Plan.
  • [F2]These options become exerciseable in annual 25% increments, commencing on the date shown forth in Table II, Column 6.
  • [F3]These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
  • [F4]Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
  • [F5]Consists of restricted stock units granted to the reporting person. One third of the restricted stock units will vest and the underlying shares will be issued to the reporting person on each of May 29, 2021, May 29, 2022 and May 29, 2023, so long as the reporting person continues to be employed by the issuer on the vesting dates.

Documents

2 files

Issuer

ABIOMED INC

CIK 0000815094

→
Entity typeother

Related Parties

1
  • filerCIK 0001456804

Filing Metadata

Form type
4
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 8:35 PM ET
Size
20.3 KB
View on SEC.gov